- Home
- PRZO vs ABVC Comparison
PRZO vs ABVC Comparison
Compare PRZO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- ABVC
- Stock Information
- Founded
- PRZO 2014
- ABVC 2015
- Country
- PRZO Israel
- ABVC United States
- Employees
- PRZO N/A
- ABVC N/A
- Industry
- PRZO
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- ABVC Health Care
- Exchange
- PRZO Nasdaq
- ABVC Nasdaq
- Market Cap
- PRZO 20.1M
- ABVC 22.1M
- IPO Year
- PRZO 2023
- ABVC N/A
- Fundamental
- Price
- PRZO $1.35
- ABVC $3.15
- Analyst Decision
- PRZO
- ABVC
- Analyst Count
- PRZO 0
- ABVC 0
- Target Price
- PRZO N/A
- ABVC N/A
- AVG Volume (30 Days)
- PRZO 1.7M
- ABVC 436.6K
- Earning Date
- PRZO 03-21-2025
- ABVC 08-13-2025
- Dividend Yield
- PRZO N/A
- ABVC N/A
- EPS Growth
- PRZO N/A
- ABVC N/A
- EPS
- PRZO N/A
- ABVC N/A
- Revenue
- PRZO $932,154.00
- ABVC $508,383.00
- Revenue This Year
- PRZO N/A
- ABVC $735.18
- Revenue Next Year
- PRZO N/A
- ABVC N/A
- P/E Ratio
- PRZO N/A
- ABVC N/A
- Revenue Growth
- PRZO 50.22
- ABVC 1904.43
- 52 Week Low
- PRZO $0.49
- ABVC $0.40
- 52 Week High
- PRZO $3.16
- ABVC $3.12
- Technical
- Relative Strength Index (RSI)
- PRZO 61.79
- ABVC 69.63
- Support Level
- PRZO $1.12
- ABVC $2.16
- Resistance Level
- PRZO $1.30
- ABVC $3.10
- Average True Range (ATR)
- PRZO 0.10
- ABVC 0.26
- MACD
- PRZO 0.00
- ABVC 0.09
- Stochastic Oscillator
- PRZO 78.79
- ABVC 85.29
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.